These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 8421998

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
    Brilla CG, Matsubara LS, Weber KT.
    J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
    [Abstract] [Full Text] [Related]

  • 3. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat.
    Brilla CG, Weber KT.
    Cardiovasc Res; 1992 Jul; 26(7):671-7. PubMed ID: 1423431
    [Abstract] [Full Text] [Related]

  • 4. Aldosterone and myocardial fibrosis in heart failure.
    Brilla CG.
    Herz; 2000 May; 25(3):299-306. PubMed ID: 10904856
    [Abstract] [Full Text] [Related]

  • 5. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG, Schencking M, Scheer C, Rupp H.
    Praxis (Bern 1994); 1997 Apr 02; 86(14):566-74. PubMed ID: 9198851
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
    López-Andrés N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, Fortuno MA, Cachofeiro V, Díez J.
    Am J Physiol Heart Circ Physiol; 2011 Dec 02; 301(6):H2372-82. PubMed ID: 21926338
    [Abstract] [Full Text] [Related]

  • 9. Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension. Response to captopril.
    Jalil JE, Janicki JS, Pick R, Weber KT.
    Am J Hypertens; 1991 Jan 02; 4(1 Pt 1):51-5. PubMed ID: 2006997
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
    Neves MF, Amiri F, Virdis A, Diep QN, Schiffrin EL, CIHR Multidisciplinary Research Group on Hypertension.
    Can J Physiol Pharmacol; 2005 Nov 02; 83(11):999-1006. PubMed ID: 16391708
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment with valsartan and spironolactone prevents cardiovascular remodeling in renovascular hypertensive rats.
    Okada T, Nagai M, Taniguchi I, Kuno M, Imamoto S, Seki S, Taniguchi M, Mochizuki S.
    Int Heart J; 2006 Sep 02; 47(5):783-93. PubMed ID: 17106149
    [Abstract] [Full Text] [Related]

  • 13. Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride.
    Campbell SE, Janicki JS, Matsubara BB, Weber KT.
    Am J Hypertens; 1993 Jun 02; 6(6 Pt 1):487-95. PubMed ID: 8343231
    [Abstract] [Full Text] [Related]

  • 14. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
    Azibani F, Benard L, Schlossarek S, Merval R, Tournoux F, Fazal L, Polidano E, Launay JM, Carrier L, Chatziantoniou C, Samuel JL, Delcayre C.
    Hypertension; 2012 Jun 02; 59(6):1179-87. PubMed ID: 22547442
    [Abstract] [Full Text] [Related]

  • 15. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
    Weber KT, Brilla CG.
    Circulation; 1991 Jun 02; 83(6):1849-65. PubMed ID: 1828192
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion.
    Sun Y, Ramires FJ, Weber KT.
    Cardiovasc Res; 1997 Jul 02; 35(1):138-47. PubMed ID: 9302358
    [Abstract] [Full Text] [Related]

  • 20. The effect of spironolactone on cardiac and renal fibrosis following myocardial infarction in established hypertension in the transgenic Cyp1a1Ren2 rat.
    Leader CJ, Wilkins GT, Walker RJ.
    PLoS One; 2021 Jul 02; 16(11):e0260554. PubMed ID: 34843581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.